Graham J. Durant
University of Toledo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Graham J. Durant.
Tetrahedron-asymmetry | 2000
Seetharamaiyer Padmanabhan; Ruth C. Lavin; Graham J. Durant
Abstract Asymmetric synthesis of N -(2-chloro-5-methylthiophenyl)- N′ -(3-methylsulfinylphenyl)- N′ -methylguanidine (CNS 5788) was achieved in high enantiomeric excess through condensation of the cyanamide derivative, 6 and the sulfinylaniline hydrochloride, 5 . The key step involved the asymmetric oxidation of N -methyl-3-methylthioaniline using a Davis reagent.
Bioorganic & Medicinal Chemistry | 1996
Babatunde Ojo; Philip G. Dunbar; Graham J. Durant; Peter I. Nagy; James J. Huzl; Sumudra Periyasamy; Dan O. Ngur; Afif A. El-Assadi; Wayne Hoss; William S. Messer
As part of a continuing effort aimed at the development of selective, efficacious, and centrally active m1 muscarinic agonists for the treatment of Alzheimers disease, a series of amide and hydrazide amidine derivatives (2a-e and 3b-d) was synthesized and examined for muscarinic agonist activity. Preliminary biochemical studies indicated that 2b, 2d, and 3d bound to muscarinic receptors in rat brain and stimulated phosphoinositide (PI) metabolism in rat cerebral cortex. Compounds 2b and 2d were also highly efficacious at m1 muscarinic receptors expressed in cultured A9 L cells. Molecular modeling studies suggest slightly different modes of interaction with m1 receptors for the ester and amide derivatives. Also, hydrogen-bond formation with a Thr residue may be important for m1 muscarinic agonist potency. The data suggest that the amide moiety can replace the ester group found in muscarinic agonists and provide further support for the utility of amidine derivatives in the development of efficacious m1 agonists.
Synthetic Communications | 1997
Seetharamaiyer Padmanabhan; N. Laxma Reddy; Graham J. Durant
Abstract Aromatic amines react with trimethyl orthoformate in the presence of concentrated sulfuric acid followed by acid hydrolysis to afford mono methylated amines in moderate to good yields.
Bioorganic & Medicinal Chemistry Letters | 1992
William S. Messer; Philip G. Dunbar; Taikyun Rho; Sumudra Periyasamy; Dan O. Ngur; Brenda R. Ellerbrock; Mark Bohnett; Kevin Ryan; Graham J. Durant; Wayne Hoss
Abstract A series of novel tetrahydropyrimidines was synthesized and examined for M 1 muscarinic receptor activity. 1,4,5,6-Tetrahydro-5-methoxycarbonyl-pyrimidine hydrobromide ( 1a ; CDD-0034-C) displayed a high affinity for muscarinic receptors in rat brain and stimulated PI metabolism in rat hippocampus. Compound 1a ameliorated memory deficits associated with lesions of the septohippocampal cholinergic system in rats.
Journal of the American Chemical Society | 1993
Peter I. Nagy; Graham J. Durant; Douglas A. Smith
Archive | 1993
Graham J. Durant; Amin Mohammed Khan
Annals of the New York Academy of Sciences | 1995
Stanley M. Goldin; Katragadda Subbarao; Rahul Sharma; Andrew Gannett Knapp; James B. Fischer; Deborah Daly; Graham J. Durant; N. Laxma Reddy; Lain-Yen Hu; Sharad Magar; Michael E. Perlman; Jun Chen; Steven H. Graham; William F. Holt; David J. Berlove; Lee David Margolin
Archive | 1993
Graham J. Durant; Sharad Magar
Archive | 1994
Graham J. Durant; Amin Mohammed Khan; Clark E. Tedford
Archive | 1993
Graham J. Durant; Amin Mohammed Khan